Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Rectal cancer
Stage/Subtype:  stage II rectal cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-13 of 13 for your search:
Start Over
Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: N1048, NCI-2012-00234, CDR0000715321, NCCTG-N1048, PN1048_A11PAMDREVW01, NCT01515787
Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: NL36315.042.11, NCI-2014-01600, 2010-023957-12, NCT01558921
Cyclodextrin-Based Polymer-Camptothecin CRLX10, Capecitabine, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced Rectal Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: LCCC 1315, NCI-2014-00897, NCT02010567
Exercise and Metformin Hydrochloride in Lowering Insulin Levels in Colorectal or Breast Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Educational/Counseling/Training, Treatment
Age: 18 and over
Trial IDs: 11-009, NCI-2011-02702, NCT01340300
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin before Surgery in Treating Patients with Stage II-III Rectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 3R-12-2, NCI-2013-01069, 3C-12-2, HS-12-00726, ML28263, NCT01871571
Chemotherapy before or after Chemoradiation Followed by Surgery or Non-operative Management in Treating Patients with Previously Untreated Stage II-III Rectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-213, NCI-2013-02356, NCT02008656
Chemoradiation or Brachytherapy before Surgery in Treating Patients with Rectal Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J1360, NCI-2014-00731, NA_00082167, NA_00082167 / CIR00008177, NCI-2014-00125, NCT02017704
Neuromodulation with Interstim Device in Reducing Bowel Dysfunction after Surgery in Patients with Rectal Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-100, NCI-2014-01368, NCT02163187
Regorafenib in Reducing Recurrence in Patients with Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 246813, NCI-2014-02202, BAY ONC-3012-036, ONC-2013-036, NCT02287727
Nitroglycerin, Fluorouracil, and Radiation Therapy in Treating Patients with Rectal Cancer That Can Be Removed by Surgery
Phase: Phase I
Type: Treatment
Age: 18 to 90
Trial IDs: VA 10-100, NCI-2011-02392, NCT01407107
Bavituximab, Capecitabine, and Radiation Therapy in Treating Patients with Stage II-III Rectal Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: STU 032012-025, NCI-2014-02136, 8843, NCI-2014-01729, NCI-2014-01933, NCT01634685
Trametinib, Fluorouracil, and Radiation Therapy before Surgery in Treating Patients with Stage II-III Rectal Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU-12054, NCI-2012-02158, 2012C0086, NCT01740648
Chinese Herbal Formulation PHY906 in Reducing Side Effects Caused by Capecitabine and Radiation Therapy in Patients with Locally Advanced Rectal Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 1404013708, NCI-2014-01560, NCT02178644
Start Over